Original Article

Occurrence and risk factors of nontuberculous mycobacteria in tuberculosis-suspected patients in the north of Iran

Abstract

Background and Objectives: Some Nontuberculous Mycobacteria (NTM) can occasionally infect the human population and cause infections having symptoms similar to tuberculosis (TB). This study tried to provide updated data about the frequency and diversity of NTM species.
Materials and Methods: Suspicious samples of Mycobacterium tuberculosis (MTB) with both positive results in Ziehl-Neelsen (ZN) staining and Löwenstein-Jensen medium culturing were evaluated during January 2016 and December 2018 in Gorgan, Iran. After determination of MTB isolates by the growth rate, pigmentation status, the niacin test, and the insertion sequence 6110 (IS6110) PCR assay, other unknown isolates (presumably NTM) were detected by the 16S rDNA sequencing method and drawing the phylogenetic tree. Based on the patients’ demographic information, their risk factors were also assessed.
Results: Among 226 culture-positive samples, obtained from 2994 individuals with suspected symptoms of TB, the analyses found 12 (5.3%) NTM and three Mycobacterium caprae isolates. Mycobacterium simiae (6/12) was the most prevalent NTM species. The average nucleotide similarity value was 98.2% ± 3.7. In comparison to patients with MTB (211 confirmed cases), other mycobacterium infections were more common in patients over 65 years old (Odd ratio (95% convenience interval): 2.96 (0.69 - 12.59), P = 0.14).
Conclusion: Although the NTM species has a small portion in TB suspected patients, their prevalence has increased, mainly in elderly patients. Moreover, M. simiae was the most prevalent NTM species in our region. Therefore, identification of common species in each region is recommended and clinicians should pay more attention to them in each region.

1. Parte AC, Carbasse JS, Meier-Kolthoff JP, Reimer LC, Göker M. List of prokaryotic names with standing in nomenclature (LPSN) moves to the DSMZ. Int J Syst Evol Microbiol 2020; 70:5607-5612.
2. Xu J, Li P, Zheng S, Shu W, Pang Y. Prevalence and risk factors of pulmonary nontuberculous mycobacterial infections in the Zhejiang Province of China. Epidemiol Infect 2019; 147:e269.
3. Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007; 175:367-416.
4. López-Roa P, Aznar E, Cacho J, Cogollos-Agruña R, Domingo D, García-Arata MI, et al. Epidemiology of Non-Tuberculous Mycobacteria isolated from clinical specimens in Madrid, Spain, from 2013 to 2017. Eur J Clin Microbiol Infect Dis 2020; 39:1089-1094.
5. Prevots DR, Marras TK. Epidemiology of human pulmonary infection with nontuberculous mycobacteria: a review. Clin Chest Med 2015; 36:13-34.
6. McShane PJ, nd Glassroth J. Pulmonary disease due to nontuberculous mycobacteria: current state and new insights. Chest 2015; 148:1517-1527.
7. González SM, Cortés AC, Yoldi LAS, García JMG, Álvarez LMA, Gutiérrez JJP, et al. Non-tuberculous mycobacteria. an emerging threat? Arch Bronconeumol 2017; 53:554-560.
8. World Health Organization (WHO). Global tuberculosis report 2019. Geneva, Switzerland: World Health Organization; 2019; https://www.who.int/teams/global-tuberculosis-programme/tb-reports
9. Jain S, Sankar MM, Sharma N, Singh S, Chugh TD. High prevalence of non-tuberculous mycobacterial disease among non-HIV infected individuals in a TB endemic country – experience from a tertiary center in Delhi, India. Pathog Glob Health 2014; 108:118-122.
10. Ravikiran MR, Sagar MR, Yanlin Z, Eric JR. Leveraging advances in tuberculosis diagnosis and treatment to address nontuberculous mycobacterial disease. Emerg Infect Dis 2016; 22:365-369.
11. López-Varela EL, García-Basteiro A, Augusto OJ, Fraile O, Bulo H, Ira T, et al. High rates of non-tuberculous mycobacteria isolation in Mozambican children with presumptive tuberculosis. PLoS One 2017; 12(1):e0169757.
12. Shahraki AH, Heidarieh P, Bostanabad SZ, Khosravi AD, Hashemzadeh M, Khandan S, et al. “Multidrug-resistant tuberculosis” may be nontuberculous mycobacteria. Eur J Intern Med 2015; 26:279-284.
13. Van Ingen J, Bendien SA, De Lange WCM, Hoefsloot W, Dekhuijzen PNR, Boeree MJ, et al. Clinical relevance of non-tuberculous mycobacteria isolated in the Nijmegen-Arnhem region, The Netherlands. Thorax 2009; 64:502-506.
14. Dibaj R, Shojaei H, Narimani T. Identification and molecular characterization of mycobacteria isolated from animal sources in a developing country. Acta Trop 2020; 204:105297.
15. Larsson L-O, Bennet R, Eriksson M, Jönsson B, Ridell M (2019). Nontuberculous mycobacterial diseases in humans. In: Nontuberculous Mycobacteria (NTM). Elsevier, Academic Press, pp. 101-119.
16. Nasiri MJ, Dabiri H, Fooladi AAI, Amini S, Hamzehloo G, Feizabadi MM. High rates of nontuberculous mycobacteria isolation from patients with presumptive tuberculosis in Iran. New Microbes New Infect 2017; 21:12-17.
17. Grange JM, Yates MD, Kantor IN de, World Health Organization (1996). Guidelines for speciation within the Mycobacterium tuberculosis complex. No. WHO/EMC/ZOO/96.4. Geneva: World Health Organization.
18. Eisenach KD, Donald Cave M, Bates JH, Crawford JT. Polymerase chain reaction amplification of a repetitive DNA sequence specific for Mycobacterium tuberculosis. J Infect Dis 1990; 161:977-981.
19. Rogall T, Flohr T, Böttger EC. Differentiation of Mycobacterium species by direct sequencing of amplified DNA. J Gen Microbiol 1990; 136:1915-1920.
20. Tamura K, Stecher G, Peterson D, Filipski A, Kumar S. MEGA6: molecular evolutionary genetics analysis version 6.0. Mol Biol Evol 2013; 30:2725-2729.
21. Mirsaeidi M, Farnia P, Sadikot R, Hsueh P-R, Aliberti S. Nontuberculous mycobacteria: epidemiologic, mycobacteriologic, and clinical aspects. Biomed Res Int 2015;2015:523697.
22. Khosravi AD, Asban B, Hashemzadeh M, Nashibi R. Molecular identification, and characterization of Mycobacterium kansasii strains isolated from four tuberculosis regional reference laboratories in Iran during 2016-2018. Infect Drug Resist 2020; 13:2171-2180.
23. Nasiri MJ, Dabiri H, Darban-Sarokhalil D, Shahraki AH. Prevalence of non-tuberculosis mycobacterial infections among tuberculosis suspects in Iran: systematic review and meta-analysis. PLoS One 2015; 10(6):e0129073.
24. Ghaemi E, Ghazisaidi K, Koohsari H, Khodabakhshi B, Mansoorian A. Environmental mycobacteria in areas of high and low tuberculosis prevalence in the Islamic Republic of Iran. East Mediterr Health J 2006; 12:280-285.
25. Moore JE, Kruijshaar ME, Ormerod LP, Drobniewski F, Abubakar I. Increasing reports of non-tuberculous mycobacteria in England, Wales and Northern Ireland, 1995-2006. BMC Public Health 2010; 10:612.
26. Yu X, Liu P, Liu G, Zhao L, Hu Y, Wei G, et al. The prevalence of non-tuberculous mycobacterial infections in mainland China: systematic review and meta-analysis. J Infect 2016; 73:558-567.
27. Roux A-L, Catherinot E, Ripoll F, Soismier N, Macheras E, Ravilly S, et al. Multicenter study of prevalence of nontuberculous Mycobacteria in patients with cystic fibrosis in France. J Clin Microbiol 2009; 47:4124-4128.
28. Nasiri MJ, Feizabadi MM, Dabiri H, Imani Fooladi AA. Prevalence of nontuberculous Mycobacteria: A single center study in Tehran, Iran. Arch Clin Infect Dis 2018; 13 (3); e61042.
29. Pang Y, Tan Y, Chen J, Li Y, Zheng H, Song Y, et al. Diversity of nontuberculous mycobacteria in eastern and southern China: a cross-sectional study. Eur Respir J 2017; 49:1601429.
30. Lai C-C, Tan C-K, Chou C-H, Hsu H-L, Liao C-H, Huang Y-T, et al. Increasing incidence of nontuberculous mycobacteria, Taiwan, 2000–2008. Emerg Infect Dis 2010; 16:294-296.
Files
IssueVol 13 No 2 (2021) QRcode
SectionOriginal Article(s)
DOI https://doi.org/10.18502/ijm.v13i2.5980
Keywords
Nontuberculous mycobacteria; Tuberculosis; 16S rDNA; Sequence alignment; Sequence homology; Mycobacterium simiae; Mycobacterium virginiense
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Shafipour M, Shirzad-Aski H, Ghaemi EA, Sohrabi A, Taziki M, Babai Kochkaksaraei M, Rahimi S. Occurrence and risk factors of nontuberculous mycobacteria in tuberculosis-suspected patients in the north of Iran. Iran J Microbiol. 2021;13(2):190-198.